Therapeutic monoclonal antibodies: scFv patents as a marker of a new class of potential biopharmaceuticals . (2011). Brazilian Journal of Pharmaceutical Sciences, 47(1), 31-38. https://doi.org/10.1590/S1984-82502011000100005